![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 2.68 | 4.69 | 0.693 | 0.949 |
Gross Profit | -1.38 | 0.477 | -1.88 | -2.48 |
Operating Income | -3.14 | -1.59 | -3.48 | -4.64 |
Net Income | -3.42 | -1.82 | -3.71 | -4.7 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 55.17 | 59.11 | 60.11 | 55.48 |
Total Liabilities | 23.49 | 24 | 23.18 | 14.85 |
Total Equity | 31.68 | 35.1 | 36.93 | 40.63 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -2.94 | -3.82 | -1.31 | 4.32 |
Cash From Investing Activities | -0.606 | -0.77 | -0.029 | |
Cash From Financing Activities | -0.183 | 1.66 | 6.08 | -0.32 |
Net Change in Cash | -3.73 | -2.93 | 4.74 | 4 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review